BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1318530)

  • 1. A routine method for using sodium iodide to stabilize sodium pertechnetate [99Tcm] dispensed for the preparation of 99Tcm-exametazime.
    Millar AM
    Nucl Med Commun; 1992 May; 13(5):306-11. PubMed ID: 1318530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
    Millar AM
    Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pertechnetate source and age on the radiochemical purity of technetium Tc 99m exametazime.
    Ponto JA
    Am J Hosp Pharm; 1990 Nov; 47(11):2511-3. PubMed ID: 2177584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stability of 99Tcm bone scan preparations from different manufacturers measured by various radiopharmaceutical parameters.
    Pauwels EK; Feitsma RI
    Nucl Med Commun; 1984 Jul; 5(7):467-72. PubMed ID: 6099535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and storage of single-dose portions of exametazime: effects on radiochemical purity after labeling.
    Cheng KT; Spicer KM; Deshpande RV
    Am J Hosp Pharm; 1992 Aug; 49(8):1950-4. PubMed ID: 1332470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and properties of 99Tcm-exametazime using stannous ion augmentation of fractionated cold kits.
    Baker RJ
    Nucl Med Commun; 1999 Mar; 20(3):287-93. PubMed ID: 10093080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization and multidose use of exametazime for cerebral perfusion studies.
    Solanki C; Li DJ; Wong A; Barber RW; Wraight EP; Sampson CB
    Nucl Med Commun; 1994 Sep; 15(9):718-22. PubMed ID: 7816385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of three methods to determine the radiochemical purity of 99Tcm-hexamethylpropylene amine oxime (99Tcm-HMPAO).
    Mah G; Reilly RM; Wong GL; Houle S
    Nucl Med Commun; 1989 Oct; 10(10):733-40. PubMed ID: 2616098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiochemical purity testing for 99Tcm-exametazime: a comparison study for three-paper chromatography.
    Hung JC; Taggart TR; Wilson ME; Owens TP
    Nucl Med Commun; 1994 Jul; 15(7):569-74. PubMed ID: 7970436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
    Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
    Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of generator eluate age on the radiochemical purity of fractionated 99Tcm-MAG3.
    Hung JC; Thorson LM
    Nucl Med Commun; 1995 Mar; 16(3):157-60. PubMed ID: 7770239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term stability of reconstituted exametazime: a clinical and laboratory evaluation.
    Hawkins T; Reeder A; Keavey PM; Thakker S; Hawker R
    Nucl Med Commun; 1991 Dec; 12(12):1045-55. PubMed ID: 1811199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for stabilising technetium-99m exametazime prepared from a commercial kit.
    Weisner PS; Bower GR; Dollimore LA; Forster AM; Higley B; Storey AE
    Eur J Nucl Med; 1993 Aug; 20(8):661-6. PubMed ID: 8404951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99Tcm-MAG3: in vitro stability and in vivo behaviour at different times after preparation.
    Millar AM; Wilkinson AG; McAteer E; Best JJ
    Nucl Med Commun; 1990 Jun; 11(6):405-12. PubMed ID: 2143569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven-hour stabilization of 99Tcm-exametazime (HMPAO) for cerebral perfusion.
    Solanki C; Wraight EP; Barber RW; Sampson CB
    Nucl Med Commun; 1998 Jun; 19(6):567-72. PubMed ID: 10234661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of generator eluate on the radiochemical purity of 99Tcm-sestamibi prepared using fractionated Cardiolite kits.
    Varelis P; Parkes SL; Poot MT
    Nucl Med Commun; 1998 Jul; 19(7):615-23. PubMed ID: 9853341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes.
    Koslowsky IL; Brake SE; Bitner SJ
    J Nucl Med Technol; 2001 Dec; 29(4):197-200. PubMed ID: 11756532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid and stable ITLC procedure for the determination of the radiochemical purity of 99Tcm-tetrofosmin.
    van Hemert FJ; Schimmel KJ; van Eck-Smit BL
    Nucl Med Commun; 2001 Jun; 22(6):641-4. PubMed ID: 11403174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of sodium iodide to overcome the eluate age restriction for Ceretec reconstitution.
    Bayne VJ; Forster AM; Tyrrell DA
    Nucl Med Commun; 1989 Jan; 10(1):29-33. PubMed ID: 2919029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
    Lerthirunwong C; Cheng KT; Hladik WB
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.